{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:21:32Z","timestamp":1789701692251,"version":"4.0.1"},"reference-count":187,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T00:00:00Z","timestamp":1406678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijpddr.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T09:45:22Z","timestamp":1408873522000},"page":"326-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery"],"prefix":"10.1016","volume":"4","author":[{"given":"Rafael","family":"Bala\u00f1a-Fouce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"\u00c1lvarez-Velilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fern\u00e1ndez-Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Garc\u00eda-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Reguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2014.07.006_b0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0092-8674(91)90215-K","article-title":"Chromosome assembly in vitro: topoisomerase II is required for condensation","volume":"64","author":"Adachi","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(03)53002-0","article-title":"Interactions between tsetse and trypanosomes with implications for the control of trypanosomiasis","volume":"53","author":"Aksoy","year":"2003","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h)1\/Th2 and Leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0025","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0030","first-page":"26","article-title":"DNA packaging: nucleosomes and chromatin","volume":"1","author":"Annunziato","year":"2008","journal-title":"Nat. Educ."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0035","first-page":"175","article-title":"DNA topoisomerase II inhibitors","volume":"76","author":"Anonymous","year":"2000","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10096-011-1276-0","article-title":"Leishmaniasis: new insights from an old and neglected disease","volume":"31","author":"Antinori","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/mol.104.003889","article-title":"Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison","volume":"67","author":"Antony","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0050","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1093\/nar\/26.18.4205","article-title":"Toprim: a conserved catalytic domain in type IA and II topoisomerases, DNAG-type primases, OLD family nucleases and RecR proteins","volume":"26","author":"Aravind","year":"1998","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0055","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0020-7519(00)00136-3","article-title":"The leishmaniasis as emerging and reemerging zoonoses","volume":"30","author":"Ashford","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.molbiopara.2004.04.006","article-title":"RNA interference of Trypanosoma brucei topoisomerase IB: both subunits are essential","volume":"136","author":"Bakshi","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1128\/AAC.00650-07","article-title":"Activity of indenoisoquinolines against African trypanosomes","volume":"53","author":"Bakshi","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-3623(97)00268-1","article-title":"The pharmacology of leishmaniasis","volume":"30","author":"Bala\u00f1a-Fouce","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.drudis.2006.06.014","article-title":"Targeting atypical trypanosomatid DNA topoisomerase","volume":"11","author":"Bala\u00f1a-Fouce","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2180-8-113","article-title":"Gene disruption of the DNA topoisomerase IB small subunit induces a non-viable phenotype in the hemoflagellate Leishmania major","volume":"8","author":"Bala\u00f1a-Fouce","year":"2008","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0085","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1128\/AAC.00499-12","article-title":"Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis","volume":"56","author":"Bala\u00f1a-Fouce","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2958.2010.07318.x","article-title":"A tyrosyl DNA phosphodiesterase 1 from kinetoplastid parasite Leishmania donovani (LdTdp1) capable of removing topo I-DNA covalent complexes","volume":"78","author":"Banerjee","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0095","first-page":"230542","article-title":"Identification of a functional type IA topoisomerase, LdTopIIIb, from kinetoplastid parasite Leishmania donovani","author":"Banerjee","year":"2011","journal-title":"Enz. Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bmb\/lds031","article-title":"Management of trypanosomiasis and leishmaniasis","volume":"104","author":"Barrett","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0105","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1021\/bi700789g","article-title":"Energy coupling in type II topoisomerases: why do they hydrolyze ATP?","volume":"46","author":"Bates","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0110","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1021\/bi9005978","article-title":"The QTK loop is essential for the communication between the N-terminal atpase domain and the central cleavage\u2013ligation region in human topoisomerase IIalpha","volume":"48","author":"Bendsen","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/379225a0","article-title":"Structure and mechanism of DNA topoisomerase II","volume":"379","author":"Berger","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0120","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425255.4.9.1209","article-title":"Treatment of leishmaniasis with miltefosine: 2008 status","volume":"4","author":"Berman","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"Bhattacharya","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0130","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1074\/jbc.275.17.13041","article-title":"Communication between the ATPase and cleavage\/religation domains of human topoisomerase II\u03b1","volume":"275","author":"Bjergbaek","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0135","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.92.9.3726","article-title":"Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania","volume":"92","author":"Bodley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0140","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1073\/pnas.1330762100","article-title":"An unusual type IB topoisomerase from African trypanosomes","volume":"100","author":"Bodley","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2958.2007.06002.x","article-title":"The large subunit of Leishmania topoisomerase I functions as the \u2018molecular steer\u2019 in type IB topoisomerase","volume":"67","author":"BoseDasgupta","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0150","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jmb.2004.05.034","article-title":"DNA disentangling by type-2 topoisomerases","volume":"340","author":"Buck","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0155","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1017\/S0031182010001137","article-title":"Chemotherapy against human African trypanosomiasis: is there a road to success?","volume":"137","author":"Burri","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0169-4758(96)10017-X","article-title":"Topoisomerases in kinetoplastids","volume":"12","author":"Burri","year":"1996","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0165","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1046\/j.1365-2958.1997.5241885.x","article-title":"Nicking by transesterification: the reaction catalysed by a relaxase","volume":"25","author":"Byrd","year":"1997","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chemphyslip.2013.05.002","article-title":"Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids","volume":"172\u2013173","author":"Carballeira","year":"2013","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0175","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s11745-009-3345-z","article-title":"Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid","volume":"44","author":"Carballeira","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0180","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1016\/j.tetlet.2010.09.083","article-title":"The first total synthesis of the (\u00b1)-17-methyl-trans-4,5-methyleneoctadecanoic acid and related analogs with antileishmanial activity","volume":"51","author":"Carballeira","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0185","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1016\/j.bmcl.2012.08.019","article-title":"2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani","volume":"22","author":"Carballeira","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0166-6851(87)90074-0","article-title":"Decatenation of kinetoplast DNA by an ATP-dependent DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani","volume":"26","author":"Chakraborty","year":"1987","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0006-291X(88)80081-0","article-title":"Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani","volume":"152","author":"Chakraborty","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-291X(05)81289-6","article-title":"An ATP-independent catenating enzyme from the kinetoplast hemoflagellate Leishmania donovani","volume":"180","author":"Chakraborty","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1073\/pnas.69.1.143","article-title":"An activity from mammalian cells that untwists superhelical DNA \u2013 a possible swivel for DNA replication","volume":"69","author":"Champoux","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0169-4758(00)01697-5","article-title":"The topoisomerases of protozoan parasites","volume":"16","author":"Cheesman","year":"2000","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0092-8674(95)90451-4","article-title":"The topology of the kinetoplast DNA network","volume":"80","author":"Chen","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0225","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1002\/j.1460-2075.1995.tb00325.x","article-title":"Changes in network topology during the replication of kinetoplast DNA","volume":"14","author":"Chen","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0230","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81411-7","article-title":"Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases","volume":"92","author":"Cheng","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03402104","article-title":"Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy","volume":"9","author":"Chowdhury","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.exppara.2007.02.018","article-title":"Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine","volume":"116","author":"Cort\u00e1zar","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0250","first-page":"91","article-title":"Human DNA topoisomerase IB: structure and functions","volume":"56","author":"Cretaio","year":"2007","journal-title":"Ital. J. Biochem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0255","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2013challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0260","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/nar\/29.9.1844","article-title":"Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy","volume":"29","author":"Das","year":"2001","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0265","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pt.2004.06.005","article-title":"Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets","volume":"20","author":"Das","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0270","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/nar\/gkj502","article-title":"Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I","volume":"34","author":"Das","year":"2006","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0275","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2958.2006.05428.x","article-title":"Topoisomerases of kinetoplastid parasites: why so fascinating?","volume":"62","author":"Das","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-0-387-77570-8_9","article-title":"DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy","volume":"625","author":"Das","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0285","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jmb.2006.01.022","article-title":"The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA","volume":"357","author":"Davies","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0290","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/00365540310017023","article-title":"Characterization of Leishmania chagasi DNA topoisomerase II: a potential chemotherapeutic target","volume":"35","author":"De Sousa","year":"2003","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0295","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.actatropica.2005.01.005","article-title":"Antitrypanosomal activities of DNA topoisomerase inhibitors","volume":"93","author":"Deterding","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0300","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/187152008784220357","article-title":"Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy","volume":"8","author":"Dexheimer","year":"2008","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0305","doi-asserted-by":"crossref","first-page":"e1177","DOI":"10.1371\/journal.pone.0001177","article-title":"Deletion study of DNA topoisomerase IB from Leishmania donovani: searching for a minimal functional heterodimer","volume":"2","author":"D\u00edaz Gonz\u00e1lez","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0310","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.biochi.2007.07.015","article-title":"Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani","volume":"89","author":"D\u00edaz Gonz\u00e1lez","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0315","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bcp.2008.06.019","article-title":"Mutational study of the \u201ccatalytic tetrad\u201d of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: role of Asp-353 and Asn-221 in camptothecin resistance","volume":"76","author":"D\u00edaz-Gonz\u00e1lez","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0320","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.phymed.2009.08.002","article-title":"Antiprotozoal activity of betulinic acid derivatives","volume":"17","author":"Dom\u00ednguez-Carmona","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0325","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1073\/pnas.83.19.7152","article-title":"ATP independent type II topoisomerase from trypanosomes","volume":"83","author":"Douc-Rasy","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0330","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568026033452537","article-title":"Fluoroquinolones: action and resistance","volume":"3","author":"Drlica","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0335","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jmb.2006.04.021","article-title":"A universal type IA topoisomerase fold","volume":"359","author":"Duguet","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0340","doi-asserted-by":"crossref","first-page":"43268","DOI":"10.1074\/jbc.M303899200","article-title":"Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I","volume":"278","author":"Fiorani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0345","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.biochi.2006.12.009","article-title":"Origin and evolution of DNA topoisomerases","volume":"89","author":"Forterre","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0350","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0166-6851(92)90133-5","article-title":"Cloning and characterization of the gene encoding Trypanosoma cruzi DNA topoisomerase II","volume":"55","author":"Fragoso","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0166-6851(98)00066-8","article-title":"Expression and cellular localization of Trypanosoma cruzi type II DNA topoisomerase","volume":"94","author":"Fragoso","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0360","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.phytochem.2006.05.039","article-title":"Antiprotozoal and cytotoxic naphthalene derivatives from Diospyros assimilis","volume":"67","author":"Ganapaty","year":"2006","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0365","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1021\/jm970232h","article-title":"Structure\u2013activity relationships for the antileishmanial and antitrypanosomal activities of 1\u2032-substituted 9-anilinoacridines","volume":"40","author":"Gamage","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0370","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/emboj\/18.6.1701","article-title":"The essential role of yeast topoisomerase III in meiosis depends on recombination","volume":"18","author":"Gangloff","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0375","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jac\/40.2.287","article-title":"Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum","volume":"40","author":"Gangneux","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0380","first-page":"1777","article-title":"DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery","volume":"277","author":"Garc\u00eda-Estrada","year":"2010","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0385","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.actatropica.2009.07.019","article-title":"Chagas disease in Spain, the United States and other non-endemic countries","volume":"115","author":"Gascon","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0390","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2836(86)80010-9","article-title":"Metaphase chromosome structure involvement of topoisomerase II","volume":"188","author":"Gasser","year":"1986","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0395","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/AAC.34.9.1707","article-title":"Trypanosoma cruzi proliferation and differentiation are blocked by topoisomerase II inhibitors","volume":"34","author":"Gonzales-Perdomo","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0400","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"Goto","year":"2010","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0405","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0410","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1093\/nar\/gkg671","article-title":"Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs","volume":"31","author":"Hanke","year":"2003","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0415","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0035-9203(87)90013-7","article-title":"Antiprotozoal activity of diospyrin towards Leishmania donovani promastigotes in vitro","volume":"81","author":"Hazra","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0420","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-6851(97)00076-5","article-title":"Periodic synthesis of kinetoplast DNA type II topoisomerases during the cell cycle","volume":"88","author":"Hines","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0425","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA break via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0430","first-page":"5077","article-title":"Arrest of replication forks by drugs stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin","volume":"49","author":"Hsiang","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0435","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11060-012-1023-0","article-title":"Phase II trial of oral gimatecan for recurrent glioblastoma","volume":"111","author":"Hu","year":"2013","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0440","doi-asserted-by":"crossref","first-page":"25820","DOI":"10.1074\/jbc.M002144200","article-title":"Expression of human topoisomerase I with a partial deletion of the linker region yields monomeric and dimeric enzymes that respond differently to camptothecin","volume":"275","author":"Ireton","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0445","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-micro-092611-150057","article-title":"Network news: the replication of kinetoplast DNA","volume":"66","author":"Jensen","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0450","doi-asserted-by":"crossref","first-page":"e1000992","DOI":"10.1371\/journal.ppat.1000992","article-title":"TOPO3alpha influences antigenic variation by monitoring expression-site-associated VSG switching in Trypanosoma brucei","volume":"6","author":"Kim","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0455","doi-asserted-by":"crossref","first-page":"17178","DOI":"10.1016\/S0021-9258(18)41910-2","article-title":"Identification of the yeast TOP3 gene product as a single strand-specific DNA topoisomerase","volume":"267","author":"Kim","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fpls.2014.00033","article-title":"The RTR complex as caretaker of genome stability and its unique meiotic function in plants","volume":"5","author":"Knoll","year":"2014","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0465","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/trstmh\/trt119","article-title":"The emergence of Leishmania major and Leishmania donovani in southern Turkey","volume":"108","author":"Koltas","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0470","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1074\/jbc.M505977200","article-title":"Trypanosoma brucei mitochondrion in the protozoan parasite topoisomerases for the nucleus and distinct genes encode type II","volume":"281","author":"Kulikowicz","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0475","first-page":"163","article-title":"Topoisomerase I inhibitors in the treatment of gastrointestinal cancer: from intravenous to oral administration","volume":"4","author":"Kuppens","year":"2004","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0480","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.101132498","article-title":"Mice lacking DNA topoisomerase III\u03b2 develop to maturity but show a reduced mean lifespan","volume":"98","author":"Kwan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0485","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1073\/pnas.0437998100","article-title":"Infertility and aneuploidy in mice lacking a type IA DNA topoisomerase III\u03b2","volume":"100","author":"Kwan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0490","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cell.2006.05.049","article-title":"Rules for nuclear localisation sequence recognition by karyopherin beta 2","volume":"126","author":"Lee","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-444-53490-3.00011-X","article-title":"Human African trypanosomiasis","volume":"114","author":"Lejon","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0500","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/bse0500121","article-title":"ABC transporters involved in drug resistance in human parasites","volume":"50","author":"Leprohon","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0505","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1046\/j.1365-2958.2000.01763.x","article-title":"Identification of a unique domain essential for Escherichia coli DNA topoisomerase III-catalysed decatenation of replication intermediates","volume":"35","author":"Li","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0510","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1365-2958.2008.06493.x","article-title":"A new function of Trypanosoma brucei mitochondrial topoisomerase II is to maintain kinetoplast DNA network topology","volume":"70","author":"Lindsay","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0515","doi-asserted-by":"crossref","unstructured":"Lindsley, J.E., 2005. DNA topology: supercoiling and linking. In: Encyclopedia of Life Sciences. John Wiley and Sons: Hoboken, NJ, pp. 1\u20137.","DOI":"10.1038\/npg.els.0003904"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0520","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pt.2005.06.008","article-title":"Felowships of the rings: the replication of kinetoplast DNA","volume":"21","author":"Liu","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0525","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.1985.3.4.562","article-title":"Amsacrine (AMSA): a clinical review","volume":"3","author":"Louie","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0530","first-page":"CD006201","article-title":"Chemotherapy for second-stage human African trypanosomiasis","volume":"6","author":"Lutje","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0535","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tvjl.2008.08.009","article-title":"Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis","volume":"182","author":"Manna","year":"2009","journal-title":"Vet. J."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0540","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1645\/GE-3161","article-title":"Effects of topoisomerases inhibitors protoberberine on Leishmania donovani growth, macrophage function, and infection","volume":"89","author":"Marquis","year":"2003","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0545","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0092-8674(88)90252-8","article-title":"Localization of a type II DNA topoisomerase to two sites at the periphery of the kinetoplast DNA of Crithidia fasciculata","volume":"55","author":"Melendy","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0550","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/S0021-9258(18)94268-7","article-title":"Novobiocin affinity purication of a mitochondrial type II topoisomerase from the trypanosomatid Crithidia fasciculata","volume":"264","author":"Melendy","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0555","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2001-17351","article-title":"In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense","volume":"67","author":"Merschjohann","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0560","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1086\/518253","article-title":"Features of apoptosis in Plasmodium falciparum erythrocytic stage through a putative role of PfMCA1 metacaspase-like protein","volume":"195","author":"Meslin","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0565","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF03401792","article-title":"Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis","volume":"6","author":"Mittra","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0570","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s40265-013-0132-1","article-title":"Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis","volume":"73","author":"Monge-Maillo","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0575","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0580","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/QCO.0b013e328359eff2","article-title":"Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis","volume":"25","author":"Mohamed-Ahmed","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0585","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1073\/pnas.0801235105","article-title":"Defective p53 engagement after the induction of DNA damage in cells deficient in topoisomerase 3\u03b2","volume":"105","author":"Mohanty","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpddr.2014.07.006_b0590","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","article-title":"Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy","volume":"104","author":"Moncayo","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0595","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/AAC.43.8.2066","article-title":"Antitrypanosomal activity of fluoroquinolones","volume":"43","author":"Nenortas","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0600","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1128\/AAC.47.9.3015-3017.2003","article-title":"Antitrypanosomal activities of fluoroquinolones with pyrrolidinyl substitutions","volume":"47","author":"Nenortas","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0605","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrc2608","article-title":"DNA topoisomerase II and its growing repertoire of biological functions","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0610","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2012.00069","article-title":"Vaccines for canine leishmaniasis","volume":"3","author":"Palatnik-de-Sousa","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0615","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0166-6851(92)90244-E","article-title":"Molecular cloning and expression of the gene encoding the kinetoplast-associated type II DNA topoisomerase of Crithidia fasciculata","volume":"50","author":"Pasion","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0620","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0625","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/cr900097c","article-title":"DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition","volume":"109","author":"Pommier","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0630","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA Topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0635","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.bbagen.2012.09.005","article-title":"A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity","volume":"1820","author":"Prada","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0640","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.bcp.2013.02.024","article-title":"Gimatecan and other camptothecin derivatives poison leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect","volume":"85","author":"Prada","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0645","doi-asserted-by":"crossref","first-page":"e73565","DOI":"10.1371\/journal.pone.0073565","article-title":"Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB","volume":"8","author":"Prada","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0650","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1128\/AAC.45.9.2623-2627.2001","article-title":"Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin","volume":"45","author":"Proulx","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0655","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0660","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.54.6.994","article-title":"Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani","volume":"54","author":"Ray","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0665","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/nar\/19.7.1399","article-title":"The C-terminal domain of the Escherichia coli DNA gyrase A subunit is a DNA-binding protein","volume":"19","author":"Reece","year":"1991","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0670","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbaexp.2006.03.006","article-title":"DNA topoisomerase I from parasitic protozoa: a potential target for chemotherapy","volume":"1759","author":"Reguera","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0675","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2174\/138945008786786118","article-title":"Characterizing the bi-subunit type IB DNA topoisomerase of Leishmania parasites; a novel scenario for drug intervention in trypanosomatids","volume":"9","author":"Reguera","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0680","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0092-8674(90)90349-J","article-title":"Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II","volume":"60","author":"Rose","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0685","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2013.10.004","article-title":"The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo","volume":"86","author":"Saha","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.ijpddr.2014.07.006_b0690","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S0074-02762007005000093","article-title":"Epidemiology of Chagas disease in non-endemic countries: the role of international migration","volume":"102","author":"Schmunis","year":"2007","journal-title":"Mem. Ins. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0695","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2958.2007.06087.x","article-title":"A mitochondrial topoisomerase IA essential for late theta structure resolution in African trypanosomes","volume":"67","author":"Scocca","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0700","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.cdd.4401435","article-title":"Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani","volume":"11","author":"Sen","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0705","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1093\/nar\/gkg727","article-title":"Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani","volume":"31","author":"Sengupta","year":"2003","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0710","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/BJ20042128","article-title":"Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide","volume":"390","author":"Sengupta","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0715","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/nar\/gki527","article-title":"Characterization of the DNA-binding domain and identification of the active site residue in the gyr A half of Leishmania donovani topoisomerase II","volume":"33","author":"Sengupta","year":"2005","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0720","first-page":"3660","article-title":"Mitochondrial topoisomerase II activity is essential for kinetoplast DNA minicircle segregation","volume":"14","author":"Shapiro","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0725","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/S0021-9258(19)84979-7","article-title":"Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II topoisomerase activity in trypanosome mitochondria","volume":"264","author":"Shapiro","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0730","first-page":"5891","article-title":"In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles","volume":"14","author":"Shapiro","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0735","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.mi.49.100195.001001","article-title":"The structure and replication of kinetoplast DNA","volume":"49","author":"Shapiro","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0740","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/1566524043360096","article-title":"The structure and replication of kinetoplast DNA","volume":"4","author":"Shlomai","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0745","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1093\/nar\/11.12.4019","article-title":"Reversible decatenation of kinetoplast DNA by a DNA topoisomerase from trypanosomatids","volume":"11","author":"Shlomai","year":"1983","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0750","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000\u20132009: the way forward","volume":"5","author":"Simarro","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0755","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S0031182012000169","article-title":"Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis","volume":"139","author":"Simarro","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0760","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.actatropica.2007.06.004","article-title":"Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani","volume":"103","author":"Singh","year":"2007","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0765","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbiopara.2005.01.014","article-title":"Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani","volume":"141","author":"Singh","year":"2005","journal-title":"Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0770","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/nar\/gkp024","article-title":"Effects of magnesium and related divalent metal ions in topoisomerase structure and function","volume":"37","author":"Sissi","year":"2009","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0775","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1074\/jbc.271.13.7602","article-title":"The domain organization of human topoisomerase I","volume":"271","author":"Stewart","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0780","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/jmbi.1997.1056","article-title":"Reconstitution of human topoisomerase I by fragment complementation","volume":"269","author":"Stewart","year":"1997","journal-title":"J. Biol. Mol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0785","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A model for the mechanism of human topoisomerase I","volume":"279","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0790","doi-asserted-by":"crossref","first-page":"32950","DOI":"10.1074\/jbc.274.46.32950","article-title":"A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay","volume":"274","author":"Stewart","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0795","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0166-6851(90)90214-7","article-title":"The TOP2 gene of Trypanosoma brucei: a single-copy gene that shares extensive homology with other TOP2 genes encoding eukaryotic DNA topoisomerase II","volume":"38","author":"Strauss","year":"1990","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0800","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2958.2002.03028.x","article-title":"RNA editing: complexity and complications","volume":"45","author":"Stuart","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0805","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0810","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1128\/AAC.01025-09","article-title":"Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes","volume":"54","author":"Tang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0815","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.50.4.1352-1364.2006","article-title":"Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure\u2013activity relationship, and quantitative structure\u2013activity relationship studies","volume":"50","author":"Tasdemir","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0820","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/CMR.00063-10","article-title":"Pathogenesis of chagas\u2019 disease: parasite persistence and autoimmunity","volume":"24","author":"Teixeira","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0825","doi-asserted-by":"crossref","first-page":"e24100","DOI":"10.1371\/journal.pone.0024100","article-title":"Identification of a phosphorylation-dependent nuclear localization motif in interferon regulatory factor 2 binding protein 2","volume":"6","author":"Teng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0830","first-page":"5908","article-title":"Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system","volume":"53","author":"Tsao","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0835","doi-asserted-by":"crossref","first-page":"9727","DOI":"10.1093\/nar\/15.23.9727","article-title":"Cloning and sequencing of Schizosaccharomyces pombe DNA topoisomerase I gene, and effect of gene disruption","volume":"15","author":"Uemura","year":"1987","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0840","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0845","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/AAC.34.5.918","article-title":"Berberine derivatives as antileishmanial drugs","volume":"34","author":"Vennerstrom","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0850","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biochi.2006.10.013","article-title":"Type IA topoisomerases: a simple puzzle?","volume":"89","author":"Viard","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0855","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0860","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1645\/GE-3347","article-title":"Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents","volume":"90","author":"Walker","year":"2004","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0865","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA topoisomerases","volume":"65","author":"Wang","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0870","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0033583598003424","article-title":"Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine","volume":"31","author":"Wang","year":"1998","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0875","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0880","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.biochem.78.030107.090101","article-title":"A journey in the world of DNA rings and beyond","volume":"78","author":"Wang","year":"2009","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0885","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1093\/emboj\/20.17.4674","article-title":"RNA interference of a trypanosome topoisomerase II causes progressive loss of mitochondrial DNA","volume":"20","author":"Wang","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0890","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj3030681","article-title":"Structure and function of type II DNA topoisomerases","volume":"303","author":"Watt","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0895","doi-asserted-by":"crossref","first-page":"37041","DOI":"10.1074\/jbc.M506520200","article-title":"Nucleotide-dependent domain movement in the ATPase domain of human type IIA DNA topoisomerase","volume":"280","author":"Wei","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0900","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.36.2.495","article-title":"Cytotoxicity of acridine compounds for Leishmania promastigotes in vitro","volume":"36","author":"Werbovetz","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-6851(94)90110-4","article-title":"Cleavable complex formation in Leishmania chagasi treated with anilinoacridines","volume":"65","author":"Werbovetz","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0910","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1586\/14737140.8.5.819","article-title":"Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma","volume":"8","author":"Wethington","year":"2008","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0915","series-title":"The Global Burden of Disease: 2004 Update","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0920","series-title":"Global Plan to Combat Neglected Tropical Diseases 2008\u20132015","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0925","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/FPC.0b013e32832e0e7f","article-title":"Etoposide pathway","volume":"19","author":"Yang","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.ijpddr.2014.07.006_b0930","doi-asserted-by":"crossref","first-page":"21426","DOI":"10.1074\/jbc.M110.123216","article-title":"Human topoisomerase IIIalpha is a single-stranded DNA decatenase that is stimulated by BLM and RMI1","volume":"285","author":"Yang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2014.07.006_b0935","doi-asserted-by":"crossref","first-page":"16206","DOI":"10.1074\/jbc.272.26.16206","article-title":"Effect of Mg(II) binding on the structure and activity of Escherichia coli DNA topoisomerase I","volume":"272","author":"Zhu","year":"1997","journal-title":"J. Biol. Chem."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320714000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320714000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:47:44Z","timestamp":1761922064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320714000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":187,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2211320714000190"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2014.07.006","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}